Cormorant Asset Management, LP Axonics, Inc. Transaction History

Cormorant Asset Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$48.64 - $62.51 $3.51 Million - $4.52 Million	-72,240 Reduced 22.42%	250,000 $14 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $19.1 Million - $24.8 Million	-370,760 Reduced 53.5%	322,240 $20.4 Million
Q3 2020 Nov 16, 2020	SELL	$35.33 - $51.04 $967,936 - $1.4 Million	-27,397 Reduced 3.8%	693,000 $35.4 Million
Q2 2020 Aug 14, 2020	SELL	$22.91 - $39.83 $1.82 Million - $3.17 Million	-79,603 Reduced 9.95%	720,397 $25.3 Million
Q1 2020 May 15, 2020	SELL	$16.44 - $37.73 $6.95 Million - $15.9 Million	-422,671 Reduced 34.57%	800,000 $20.3 Million
Q3 2019 Nov 14, 2019	SELL	$26.92 - $42.41 $802,862 - $1.26 Million	-29,824 Reduced 2.38%	1,222,671 $32.9 Million
Q2 2019 Aug 14, 2019	SELL	$18.54 - $40.97 $370,800 - $819,400	-20,000 Reduced 1.57%	1,252,495 $51.3 Million
Q1 2019 May 15, 2019	SELL	$13.32 - $24.35 $177,595 - $324,658	-13,333 Reduced 1.04%	1,272,495 $30.5 Million
Q4 2018 Feb 14, 2019	BUY	$13.2 - $16.43 $17 Million - $21.1 Million	1,285,828 New	1,285,828 $19.4 Million

235

42.8M

73.7K

230K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.45B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.